Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2019-10-09 Capital/Financing Update
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Trading Halt 3 pages 133.9KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Cellmid Limited regarding a trading halt requested pending the release of an announcement about a proposed capital raising. It references ASX Listing Rule 17.1 and states the halt is effective immediately until the earlier of normal trading resumption or the release of the capital raising announcement. The document does not contain financial statements or detailed financial data but is an announcement about a trading halt related to capital raising. According to the filing definitions, updates on company fundraising or financing activities are classified as Capital/Financing Update (CAP). The document length is 3115 characters, which is short and clearly an announcement, not a full report. Therefore, the appropriate classification is CAP with high confidence.
2019-10-09 English
New Evolis Distribution & Supply Agreements - China & Europe 3 pages 99.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement detailing new distribution agreements and market expansion activities for Cellmid's products in Europe and China. It focuses on business development, partnerships, and sales channels rather than financial results, regulatory filings, or management changes. There is no indication of financial statements, audit information, voting results, or executive changes. The content is typical of a Capital/Financing Update as it relates to company growth and distribution agreements impacting revenue streams. The document length (6683 characters) and content support this classification rather than a brief factsheet or a regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-09-30 English
Cellmid receives R&D tax credit 1 page 57.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Cellmid Limited dated 27 September 2019, stating that the company has received an $840K R&D tax credit from the Australian Taxation Office for the 2019 financial year. The content focuses on the receipt of a tax credit related to research and development expenditure. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3138 characters) and serves as a notification of a specific financial event rather than a full report or detailed financial disclosure. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory certification or officer attestation. The best fitting category is a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2019-09-26 English
Annual Report to shareholders 37 pages 2.2MB
Annual Report Classification · 100% confidence The document is titled '2019 Annual Report' and contains detailed sections typical of an annual report, including Chairman's Letter, CEO Report, Directors' Report, Corporate Governance, and Annual Financial Report. It discusses full-year financial results, strategic initiatives, operational performance, and outlook. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of the report or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2019-09-15 English
Appendix 4G and Corporate Governance Statement 23 pages 380.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures that must accompany the annual report. It includes a detailed key to disclosures against the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2019. The document is a corporate governance statement or a compliance checklist related to governance practices, not the full annual report itself. It is a regulatory filing required to be lodged with the ASX alongside the annual report but is not the annual report itself. The document is lengthy (15,000 characters) and contains detailed governance disclosures, but it is not a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other categories.
2019-09-15 English
Appendix 4E and FY19 Financial Report 74 pages 2.2MB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary Final Report' and covers the financial year ended 30 June 2019. It includes detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, and Statement of Changes in Equity. The document contains comprehensive financial data, operating results, commentary, and notes, indicating it is a full financial report for the year. Appendix 4E is a regulatory filing used in Australia for preliminary final reports, which are equivalent to annual reports or 10-K filings in other jurisdictions. The length of the document (15,000 characters) and the presence of detailed financial statements confirm it is not merely an announcement or certification. Therefore, the document should be classified as an Annual Report (10-K). FY 2019
2019-08-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.